Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency

Acta Paediatrica, International Journal of Paediatrics

Volumn 103, Issue 11, 2014, Pages 1102-1109

  Olusanya, Bolajoko O ^a   Emokpae, Abieyuwa A ^b   Zamora, Tara G ^c   Slusher, Tina M ^c  

^a Centre for Healthy Start Initiative   (Nigeria)

^b Massey Street Children Hospital   (Nigeria)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute bilirubin encephalopathy; Child disability; Developing countries; Kernicterus; Phototherapy

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADVERSE OUTCOME; EXCHANGE BLOOD TRANSFUSION; FOLLOW UP; GENE FREQUENCY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE AVAILABILITY; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MATERNAL WELFARE; MORBIDITY; NEONATAL HYPERBILIRUBINEMIA; NEWBORN JAUNDICE; NEWBORN MORTALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; COMPLICATION; COST OF ILLNESS; DEVELOPING COUNTRY; HYPERBILIRUBINEMIA, NEONATAL; NEWBORN; POVERTY; SEVERITY OF ILLNESS INDEX;

COST OF ILLNESS; DEVELOPING COUNTRIES; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INCIDENCE; INFANT, NEWBORN; POVERTY; SEVERITY OF ILLNESS INDEX;

EID: 84922878411     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12735     Document Type: Review

References (56)

1. Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM,. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics 2009; 123: 524-32.
2. The Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet 2008; 371: 135-42.
3. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al., G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 2012; 9: e1001339.
4. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E,. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009; 42: 267-78.
5. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 1989; 67: 601-11.
6. Cappellini MD, Fiorelli G,. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371: 64-74.
7. Olusanya BO, Slusher TM,. Reducing the burden of severe neonatal jaundice in G6PD-deficient populations in low-income countries: are we doing enough? Int Health 2010; 2: 22-4.
8. National Institute for Health and Clinical Excellence. Neonatal jaundice. (Clinical guideline 98.) 2010. www.nice.org.uk/CG98.
9. American Academy of Pediatrics (AAP). Management of hyperbilirubinaemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
10. Wickremasinghe AC, Kuzniewicz MW, Newman TB,. Black race is not protective against hazardous bilirubin levels. J Pediatr 2013; 162: 1068-9.
11. Kaplan M, Slusher T, Renbaum P, Essiet DF, Pam S, Levy-Lahad E, et al., (TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates. Pediatr Res 2008; 63: 109-11.
12. Beutler E, Gelbart T, Demina A,. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95: 8170-4.
13. Chitty HE, Ziegler N, Savoia H, Doyle LW, Fox LM,. Neonatal exchange transfusions in the 21st century: a single hospital study. J Paediatr Child Health 2013; 49: 825-32.
14. Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG,. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007; 120: 27-32.
15. Owa JA, Ogunlesi TA,. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr 2009; 5: 51-5.
16. Hameed NN, Na' Ma AM, Vilms R, Bhutani VK,. Severe neonatal hyperbilirubinaemia and adverse short-term consequences in Baghdad, Iraq. Neonatology 2011; 100: 57-63.
17. English M, Ngama M, Musumba C, Wamola B, Bwika J, Mohammed S, et al., Causes and outcome of young infant admissions to a Kenyan district hospital. Arch Dis Child 2003; 88: 438-43.
18. Mwaniki MK, Atieno M, Lawn JE, Newton CR,. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012; 379: 445-52.
19. United Nations Children's Fund (UNICEF). State of the world's children 2013: children with disabilities. New York: UNICEF, 2013.
20. Olusanya BO, Akande AA, Emokpae A, Olowe SA,. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes. Trop Med Int Health 2009; 14: 301-10.
21. Tikmani SS, Warraich HJ, Abbasi F, Rizvi A, Darmstadt GL, Zaidi AK,. Incidence of neonatal hyperbilirubinaemia: a population-based prospective study in Pakistan. Trop Med Int Health 2010; 15: 502-7.
22. McGillivray A, Evans N,. Severe neonatal jaundice: is it a rare event in Australia? J Paediatr Child Health 2012; 48: 801-7.
23. Van Winckel M, De Bruyne R, Van De Velde S, Van Biervliet S, Vitamin K,. An update for the paediatrician. Eur J Pediatr 2009; 168: 127-34.
24. Lane PA, Hathaway WE,. Vitamin K in infancy. J Pediatr 1985; 106: 351-9.
25. Mwaniki MK, Gatakaa HW, Mturi FN, Chesaro CR, Chuma JM, Peshu NM, et al., An increase in the burden of neonatal admissions to a rural district hospital in Kenya over 19 years. BMC Public Health 2010; 10: 591.
26. Turner C, Carrara V, Aye Mya Thein N, Chit Mo Mo Win N, Turner P, Bancone G, et al., Neonatal intensive care in a karen refugee camp: a 4 year descriptive study. PLoS One 2013; 8: e72721.
27. Amirshaghaghi A, Ghabili K, Shoja MM, Kooshavar H,. Neonatal jaundice: knowledge and practice of Iranian mothers with icteric newborns. Pak J Biol Sci 2008; 11: 942-5.
28. Ogunlesi TA, Ogunlesi FB,. Family socio-demographic factors and maternal obstetric factors influencing appropriate health-care seeking behaviours for newborn jaundice in Sagamu, Nigeria. Matern Child Health J 2012; 16: 677-84.
29. Egube BA, Ofili AN, Isara AR, Onakewhor JU,. Neonatal jaundice and its management: knowledge, attitude, and practice among expectant mothers attending antenatal clinic at University of Benin Teaching Hospital, Benin City, Nigeria. Niger J Clin Pract 2013; 16: 188-94.
30. Iskander I, Gamaleldin R, Kabbani M,. Root causes for late presentation of severe neonatal hyperbilirubinaemia in Egypt. East Mediterr Health J 2012; 8: 882-7.
31. Madlon-Kay DJ,. Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics 1997; 100: E3.
32. Ogunlesi TA, Ogunfowora OB,. Predictors of acute bilirubin encephalopathy among Nigerian term babies with moderate-to-severe hyperbilirubinaemia. J Trop Pediatr 2011; 57: 80-6.
33. Abbasi AM, Khan MA, Ahmad M, Zafar M, Khan H, Muhammad N, et al., Medicinal plants used for the treatment of jaundice and hepatitis based on socio-economic documentation. Afr J Biotech 2009; 8: 1643-50.
34. Bazzano AN, Kirkwood BR, Tawiah-Agyemang C, Owusu-Agyei S, Adongo PB,. Beyond symptom recognition: care-seeking for ill newborns in rural Ghana. Trop Med Int Health 2008; 13: 123-8.
35. Ogunfowora OB, Daniel OJ,. Neonatal jaundice and its management: knowledge, attitude and practice of community health workers in Nigeria. BMC Public Health 2006; 6: 19.
36. Jirapaet K,. Thai healthy newborns have a higher risk. J Med Assoc Thai 2005; 88: 1314-8.
37. Rylance S, Yan J, Molyneux E,. Can transcutaneous bilirubinometry safely guide phototherapy treatment of neonatal jaundice in Malawi? Paediatr Int Child Health 2014; 34: 101-7.
38. Khassawneh M, Rubaie Z, Khashashneh I, Makhlouf F, Alkafajei A,. Adherence with American Academy of Pediatrics guidelines when managing neonatal jaundice in Jordan. Res Rep Neonatol 2013; 3: 27-31.
39. Opondo C, Ntoburi S, Wagai J, Wafula J, Wasunna A, Were F, et al., Are hospitals prepared to support newborn survival?-An evaluation of eight-first-referral level hospitals in Kenya. Trop Med Int Health 2009; 14: 1165-72.
40. Mbwele B, Reddy E, Reyburn H,. A rapid assessment of the quality of neonatal healthcare in Kilimanjaro region, northeast Tanzania. BMC Pediatr 2012; 12: 182.
41. Slusher TM, Angyo IA, Bode-Thomas F, Akor F, Pam SD, Adetunji AA, et al., Transcutaneous bilirubin measurements and serum total bilirubin levels in indigenous African infants. Pediatrics 2004; 113: 1636-41.
42. Bhutani VK, Cline BK, Donaldson KM, Vreman HJ,. The need to implement effective phototherapy in resource-constrained settings. Semin Perinatol 2011; 35: 192-7.
43. Cline BK, Vreman HJ, Faber K, Lou H, Donaldson KM, Amuabunosi E, et al., Phototherapy device effectiveness in Nigeria: irradiance assessment and potential for improvement. J Trop Pediatr 2013; 59: 321-5.
44. Okperi BO,. Neonatal jaundice and birth asphyxia as major causes of cerebral palsy in Nigeria: are doctors' wrong beliefs and practices part of the problem? Int J Med Biomed Res 2013; 2: 226-30.
45. Boo NY, Gan CY, Gian YW, Lim KS, Lim MW, et al., Malaysian mothers' knowledge & practices on care of neonatal jaundice. Med J Malaysia 2011; 66: 239-43.
46. Harrison SL, Buettner PG, MacLennan R,. Why do mothers still sun their infants? J Paediatr Child Health 1999; 35: 296-9.
47. Mishra S, Agarwal R, Deorari AK, Paul VK,. Jaundice in the newborns. Indian J Pediatr 2008; 75: 157-63.
48. Slusher TM, Vreman HJ, Olusanya BO, Wong RJ, Brearley AM, Vaucher YE, et al., Novel treatment of neonatal jaundice: safety and efficacy of filtered sunlight in African neonates. Pediatrics 2014; 133: e1568-74.
49. Slusher TM, Olusanya BO, Vreman HJ, Wong RJ, Brearley AM, Vaucher YE, et al., Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial. Trials 2013; 14: 446.
50. Sanpavat S,. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai 2005; 88: 588-92.
51. Samanta S, Kumar P, Kishore SS, Garewal G, Narang A,. Donor blood glucose 6-phosphate dehydrogenase deficiency reduces the efficacy of exchange transfusion in neonatal hyperbilirubinemia. Pediatrics 2009; 123: e96-100.
52. Gladstone M,. A review of the incidence and prevalence, types and aetiology of childhood cerebral palsy in resource-poor settings. Ann Trop Paediatr 2010; 30: 181-96.
53. Olusanya BO, Somefun AO,. Sensorineural hearing loss in infants with neonatal jaundice in Lagos: a community-based study. Ann Trop Paediatr 2009; 29: 119-28.
54. UNICEF. Violence against disabled children: un secretary general's report on violence against children. Thematic group on violence against disabled children. findings and recommendations. New York: UNICEF, 2005.
55. Hsu J, Fink D, Langer E, Carter ML, Bengo D, Ndidde S, et al., PCR-based allelic discrimination for glucose-6-phosphate dehydrogenase (g6pd) deficiency in Ugandan umbilical cord blood. Pediatr Hematol Oncol 2014; 31: 68-75.
56. De Niz M, Eziefula AC, Othieno L, Mbabazi E, Nabukeera D, Ssemmondo E, et al., Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda. Malar J 2013; 12: 210.